Article
San Francisco - New melanoma staging criteria will be "vitallyimportant" for assigning patients into various risk categories as awider variety of adjuvant therapies become available, according to CharlesM. Balch, M.D.
Bunick Highlights Efficacy and Safety of JAK Inhibitors
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Day 3 Recap: SBS 2025
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Advancing Acne Care: New Therapies and Technologies
Updates in Clinical Study of Patients of Color